| Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468) |
|---|
| 09/01/2005 | CA2555970A1 Therapeutic amide derivatives |
| 09/01/2005 | CA2555263A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands |
| 09/01/2005 | CA2555071A1 Histamine-3 receptor modulators |
| 09/01/2005 | CA2498644A1 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 08/31/2005 | EP1568367A1 Compounds effecting glucokinase |
| 08/31/2005 | EP1567504A1 Antibacterial agents |
| 08/31/2005 | EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines |
| 08/31/2005 | CN1661366A Chirality chromatogram fixed phase of antibiotics, preparation and application |
| 08/31/2005 | CN1216871C Pyridazinyl ketone derivative having insect growth regulation activity and its preparation method |
| 08/30/2005 | US6936610 Heterocyclic derivatives |
| 08/25/2005 | WO2005077915A1 Pyridazinones as antagonists of a4 integrins |
| 08/25/2005 | WO2005077914A1 PYRIDAZINONE UREAS AS ANTAGONISTS OF α4 INTEGRINS |
| 08/25/2005 | WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
| 08/25/2005 | WO2005076861A2 Compounds that inhibit hiv particle formation |
| 08/25/2005 | US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction |
| 08/25/2005 | US20050187272 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation |
| 08/25/2005 | US20050187110 Novel herbicides |
| 08/25/2005 | CA2555594A1 Pyridazinones as antagonists of a4 integrins |
| 08/25/2005 | CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins |
| 08/25/2005 | CA2555132A1 Compounds that inhibit hiv particle formation |
| 08/24/2005 | EP1565472A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure |
| 08/24/2005 | EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 08/24/2005 | CN1659148A Aryloximes |
| 08/24/2005 | CN1659147A Pyridazine derivatives |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/23/2005 | US6933311 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 08/23/2005 | US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders |
| 08/18/2005 | WO2005075438A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 08/18/2005 | WO2005075437A1 Pyridazinone derivatives and their use as pde4 inhibitors |
| 08/18/2005 | WO2005074938A1 Drug for inhibiting vascular intimal hyperplasia |
| 08/18/2005 | WO2005030794A3 Hemiasterlin derivatives and uses thereof |
| 08/18/2005 | CA2554705A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 08/17/2005 | EP1562595A1 Diaryl ethers as opioid receptor antagonists |
| 08/17/2005 | EP1562593A2 Topoisomerase-targeting agents |
| 08/17/2005 | CN1654458A Process for preparing hexahydro pyridazine tricarboxylate |
| 08/16/2005 | US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis |
| 08/16/2005 | US6930110 Nitrogen compounds such as 5-chloro-4-{4-[4-(2,3-dihydrobenzo[1,4]dioxine-5-yl)-piperazine-1-yl]-butylamino}-2H-piridazin-3-one, used as anxiolytic and hypotensive agents; side effect reduction |
| 08/11/2005 | WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| 08/10/2005 | CN1651416A Preparation method of 5-fluoro-3(2H)-pyridazinone compound |
| 08/09/2005 | US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation |
| 08/04/2005 | WO2005070891A2 Compounds and methods of use |
| 08/04/2005 | WO2004007457A3 Substituted benzylamine derivatives and methods of use |
| 08/04/2005 | US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections |
| 08/04/2005 | US20050171181 Histamine-3 receptor modulators |
| 08/04/2005 | US20050171109 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 08/04/2005 | US20050171103 Benzamide derivatives useful as histone deacetylase inhibitors |
| 08/04/2005 | US20050171102 Semicarbazide derivatives for combating thromboembolic diseases |
| 08/03/2005 | EP1558578A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 08/03/2005 | CN1649829A Novel florfenicol-type antibiotics |
| 08/03/2005 | CN1648122A Malononitrile compounds and its use |
| 08/02/2005 | US6924284 PARP inhibitors |
| 08/02/2005 | US6924251 herbicides. |
| 07/28/2005 | WO2005068445A2 Pesticidal heterocyclic dihaloallyl compounds |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050164883 agronomically tolerable salts, isomers and enantiomers of those compounds, are suitable for use as herbicides |
| 07/28/2005 | DE4243381B4 3(2H)-Pyridazinonderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie diese enthaltende Arzneimittel und ihre Verwendung 3 (2H) -pyridazinone derivatives, processes and intermediates for their preparation and pharmaceutical compositions containing them and their use |
| 07/27/2005 | EP1556354A2 Therapeutic piperazine derivates useful for treating pain |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/21/2005 | WO2005066138A1 Substituted heterocyclic amides having a fungicidal effect |
| 07/21/2005 | WO2005013914A3 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 07/20/2005 | EP1555259A1 Malononitrile compounds as pesticides |
| 07/20/2005 | EP1554267A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 07/20/2005 | EP0894087B1 Method for obtaining pure enantiomers of a pyridazinone derivative |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/19/2005 | US6919323 Pyridazinone inhibitors of fatty acid binding protein and method |
| 07/14/2005 | WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/14/2005 | US20050153984 4-[5-(4-trifluoromethyl-phenyl)-pyridin-3-yloxy]-benzothiazol-2-ylamine; inflammatory or neuropathic pain and diseases involving sensory nerve function such as asthma, rheumatoid arthritis, osteoarthritis, inflammatory bowel disorders, urinary incontinence, migraine and psoriasis |
| 07/14/2005 | US20050153960 Substituted arylamine derivatives and methods of use |
| 07/14/2005 | US20050153942 Heterocyclic inhibitors of MEK and methods of use thereof |
| 07/14/2005 | DE10360369A1 Amide Amides |
| 07/14/2005 | CA2550435A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/14/2005 | CA2550375A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/13/2005 | EP1551398A1 Pyrazolopyridines and methods of making and using the same |
| 07/13/2005 | EP1242424B1 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives |
| 07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
| 07/07/2005 | WO2005051870A3 Hydrazides and derivatives production process from hydrazines and dicarboxylic acids |
| 07/07/2005 | US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | CN1635877A Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | WO2005058845A2 Novel glucagon antagonists/inverse agonists |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | EP1546112A2 Imidazolopyridines and methods of making and using the same |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1208324C Actinomyces chain monosporamycin |
| 06/28/2005 | US6911449 For treating osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal disease, corneal ulceration, proteinu -ria, aneurysmal aortic disease, dystrophobic epidermolysis, bullosa, conditions leading to inflammatory responses |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911209 Method of treating sick sinus syndrome with levosimendan |
| 06/23/2005 | WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 06/23/2005 | WO2005033105A3 Vanilloid receptor ligands and their use in treatments |
| 06/23/2005 | US20050137397 Synthesis of hydrazine derivatives of pyridazine |